Melqart
RVMD · Medicine & biotech

Revolution Medicines

Develops pills for hard-to-treat cancers like pancreatic cancer.
Sold some
Melqart still owns 121,308 shares of Revolution Medicines, worth about $23 million, or $2 of every $100 they have in stocks. Between April and June they sold 149,055 shares (down 55%).
Mar 31
270,363
Jun 30
121,308

The numbers

Shares they own
121,308
Change since Mar 31
−149,055
−55.1%
Shares on Mar 31
270,363
Value on Jun 30, 2026
$22,718,562
about $23 million
Share of their money
2.2%
$2 of every $100 · 15th of 40
Price per share on Jun 30
$187.28
Value of the shares they sold
about $28 million
at the Jun 30 price
Kind
Shares
More about Revolution Medicines
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works